Opportunities
Search

The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.

Buyer: VERIFICACIONES INDUSTRIALES DE ANDALUCÍA, S.A. | Notice type: pin-rtl | Contract: services | Deadline: 2027-04-06

Buyer: European Commission, DG DIGIT - Digital Services | Notice type: cn-standard | Procedure: oth-mult | Contract: supplies | Deadline: 2027-04-06

The National Quantum Initiative (NQI) Act1aims to ensure the continuing leadership of the United States (U.S.) in quantum information science and technology. In conformance with the NQI goals, an argument2-5was set forth for a renewed emphasis on identifying and fostering early adoption of quantum technologies to transform the field of Quantum Information Science and Engineering (QISE) and to accelerate broader impacts on society. A systematic approach to maturing quantum technology platforms by integrating end-users and potential customers from other fields of science and engineering and other sectors of the economy into cycles of research, development, and demonstration should lower the barriers for end-users to pioneer new applications. NSF support for use-inspired and translational research in QISE, combined with continued strong support of the underlying foundational research, is anticipated to accelerate development of a market for quantum technologies. With this program solicitation, the Foundation is taking the next step in implementing the National Quantum Virtual Laboratory (NQVL) concept as an overarching shared infrastructure designed to facilitate the translation from basic science and engineering to the resultant technology, while at the same time emphasizing and advancing its scientific and technical value. The NQVL aims to develop and utilize use-inspired and application-oriented quantum technologies. In the process, NQVL researchers will explore quantum frontiers6, foster the development of QISE education and workforce development strategies, engage in outr...

Expected Outcome:Projects results are expected to contribute to the following outcomes:For supported doctoral candidates Deeper and more diverse set of research-related and transferable skills and competences;Improved employability and career prospects both within academia and beyond;New mind-sets and approaches to R&I work forged through international, inter-sectoral and interdisciplinary experience;Enhanced networking and communication capacities with scientific peers, as well as with the general public that will increase and broaden the research and innovation impact. For participating organisationsEnhanced quality and sustainability of research training;Increased global attractiveness, visibility and reputation of the participating organisation(s);Stronger R&I capacity and output among participating organisations;Increased contribution of the participating organisations to the local,...

Expected Outcome:For supported researchers:Concrete career prospects and increased career stability;Deeper and more diverse set of research-related, academic and transferable skills and competences, leading to greater autonomy. For participating organisations:Better alignment of research and Human Resources practices, including recruitment, career accession and progression systems, at participating organisation(s) with the European Charter for Researchers and the Council Recommendation of 18 December 2023 on a European framework to attract and retain research, innovation and entrepreneurial talents in Europe and the Agreement on Reforming Research Assessment;Increased global attractiveness, visibility and reputation of the participating organisation(s);Stronger R&I and teaching capacity and output;Increased contribution to the local, regional and/or national socio-economic ecosystems;Str...

Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р ХРИСТО СТАМБОЛСКИ ЕООД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-04-07

Buyer: bpost | Notice type: cn-standard | Procedure: neg-w-call | Contract: supplies | Deadline: 2027-04-09

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Courses for Skills Development

Buyer: ДЪРЖАВНА ПСИХИАТРИЧНА БОЛНИЦА - КЪРДЖАЛИ | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-04-11

Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-04-13

The Established Program to Stimulate Competitive Research is designed to fulfill the mandate of the National Science Foundation (NSF) to promote scientific progress nationwide. NSF EPSCoR facilitates the establishment of partnerships among academic institutions, government, industry, and non-profit sectors that are designed to promote sustainable improvements in a jurisdiction's research infrastructure, Research and Development (R&D) capacity, and R&D competitiveness of EPSCoR-eligible jurisdictions (i.e., states, territories, and commonwealths). Eligibility to participate in the EPSCoR funding opportunities, including the EPSCoR RII: EPSCoR Research Fellows program, is described on theNSF EPSCoR website. EPSCoR RII: EPSCoR Research Fellows directly aligns with the NSF EPSCoR strategic goal of establishing sustainable Science, Technology, Engineering, and Mathematics (STEM) professional development pathways that advance workforce development and effects engagement in STEM at national and global levels. EPSCoR RII: EPSCoR Research Fellows provides awards to build researchcapacityin institutions and transform the career trajectories of investigators and further develop their individual research potential through collaborations with investigators from the nation’s premier private, governmental, or academic research institutions and/or centers. The fellowship provides opportunities to establish strong collaborations through extended or periodic collaborative visits to a selected host site.Through collaborative research activities with the host site, Fellows will be able to lear...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. Proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The EU offers a valued operational network of clinical research sites (both interventional and observational) that have the capacity to implement well-coordinated large-scale multi-country quality clinical studies in different target populations, which are able to smoothly transition to interventions relevant for cross-border health threats in readiness for or response to a public health emergency.Key stakeholders, including relevant EU and national entities, the scientific communities, policymakers and funders enhance their collaboration and coordina...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment” and the EU Mission on Adaptation to Climate Change. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes:Populations, public authorities and healthcare systems benefit from innovative solutions and technologies to increase surveillance and prevention and reduce climatic and environmental health risks.Policymakers and public authorities develop and implement environment, climate change and health policies and interventions supported by nearly fit-for-use solutions that can be further upscaled and deployed. Scope:Enhancing the adaptive capacity and resilience of healthcare systems a...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to some of the following expected outcomes:Researchers, healthcare practitioners and providers in low- and middle-income countries (LMICs)[1] and/or those in high-income countries (HICs) serving disadvantaged populations have access to improved insights and evidence on how to equitably promote the early prevention, risk reduction, and timely diagnosis of Non-Communicable Diseases (NCDs) in children and/or young people.Policymakers, public health managers and authorities, parents and their children, and young adults have access to evidence and recommendations for national progr...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Ensuring equal access to innovative, sustainable, and high-quality healthcare”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:Patients benefit from decreased incidence of Adverse Drug Reactions (ADRs) caused by the administration of multiple medications (three or more medicinal products[1]) and enhanced health outcomes by ensuring safer and more effective use of medication.Healthcare professionals can adopt adverse drug reactions prevention and reduction strategies to integrate genetic and other biomarker information into clinical decision-making to optimise the use of medication, especially in situations of comorbidities.Healthca...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The scientific and clinical communities have a better understanding of and access to experimental monoclonal antibodies for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation.Candidate monoclonal antibody therapies are available to treat patients for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic. Scope:Infectious diseases remain a major threat to health and health security in the EU an...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Staying healthy in a rapidly changing society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:Persons with disabilities are empowered and can enjoy their rights to live independently, participate in society and be included in the community on an equal basis with others.The scientific community develops innovative solutions with a focus on removing barriers faced by persons with disabilities to live independently and they are provided with community support services where they live in the community.Policymakers, health and care services, social and service providers, disability organisations, funders, the scientific community, and...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes:Researchers, policymakers, healthcare practitioners and the public have a more comprehensive understanding of the human exposome and the interactions between climatic, environmental and socio-behavioural factors, supported by FAIR[1] data linking these exposures to disease and health outcomes.Researchers, governments, policymakers, social care services and healthcare practitioners have improved knowledge on the links between the climatic, social, lifestyle and environmental factors of the exposome and global health burden, supp...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:Biopharmaceutical industries get access to streamlined development and production processes for peptide- or protein-based biologicals.Health systems benefit from the availability of enhanced or decentralised production systems for innovative health technologies that involve peptides or proteins, and which improve health and care.Citizens and patients will benefit from better access, availability and affordability of pharmaceuticals based on biologicals. Scope:Cell-Free Protein Synthesis (CFPS) has been employe...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The scientific and clinical communities have a better understanding of and access to experimental antivirals for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation.Candidate antiviral therapies are available to treat patients for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic. Scope:Infectious diseases remain a major threat to health and health security in the EU and globally. Viral dis...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The scientific and clinical communities have a better understanding of and access to experimental monoclonal antibodies for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation.Candidate monoclonal antibody therapies are available to treat patients for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic. Scope:Infectious diseases remain a major threat to health and health security in the EU an...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The scientific and clinical communities have a better understanding of and access to new and innovative products for the treatment of antimicrobial resistant bacteria and fungi, as well as for further clinical investigation.Candidate therapies are available to treat patients for antimicrobial resistant bacteria and fungi, increasing therapeutic options for clinical deployment in the fight against Antimicrobial Resistance (AMR). Scope:The rapid rise of AMR presents a formidable threat to public health, challenging our ability to treat infe...

Buyer: DRI upravljanje investicij, Družba za razvoj infrastrukture, d.o.o. | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-04-14

The FAIROS Program seeks to support a broad range of transformative open science activities including but not limited to i.) Research, education, and socio-technical cyberinfrastructure development capacities that advance sustainable multi-disciplinary findable, accessible, interoperable, reusable (FAIR) research data management (RDM) and open science capabilities, ii.) Piloting new models of scientific communication and publication that improve efficiency and accessibility, iii.) Developing FAIROS data portals, research data commons, RDM as a national service, and iv.) Lowering barriers to accessing, curating, integrating, linking, managing, sharing, and storing data across many disciplinary domains, irrespective of data size. The program supports innovation across the cyberinfrastructure (CI) ecosystem to address accessibility, data curation, research data management, discoverability, reliability, reproducibility, preservation, sustainability, and utility of research products, including data software, and code, developed as part of funded projects. FAIROS proposals must select one of two tracks to focus on, either: 1) Disciplinary Improvements to targeted scientific communities, or 2) Cross-Cutting Improvements that apply to many or most scientific disciplines. In the case of proposals focused on Disciplinary Improvements, it is strongly recommended that prospective PIs contact a program officer from the list of Cognizant Program Officers in the directorate closest to the major disciplinary impact of the proposed work to ascertain that the scientific focus and budget of t...